Atu-1112

N/A

Report date: 2025/03/14 20:00:48

NME

Base Information

Drug NameAtu-1112

Drug Alias NameN/A

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNASmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionAngiotensin II receptor type 2 modulators

TargetsAngiotensin II receptor type 2

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSilence Therapeutics Plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSilence Therapeutics Plc

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A